SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-23-062072
Filing Date
2023-11-09
Accepted
2023-11-09 16:15:12
Documents
15
Period of Report
2023-11-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K onct-20231109.htm   iXBRL 8-K 56682
2 EX-99.1 onct-ex99_1.htm EX-99.1 126556
3 GRAPHIC img119983317_0.jpg GRAPHIC 7250
  Complete submission text file 0000950170-23-062072.txt   347135

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT onct-20231109.xsd EX-101.SCH 2902
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT onct-20231109_def.xml EX-101.DEF 13484
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT onct-20231109_pre.xml EX-101.PRE 13506
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT onct-20231109_lab.xml EX-101.LAB 16665
9 EXTRACTED XBRL INSTANCE DOCUMENT onct-20231109_htm.xml XML 4715
Mailing Address 12230 EL CAMINO REAL SUITE 230 SAN DIEGO CA 92130
Business Address 12230 EL CAMINO REAL SUITE 230 SAN DIEGO CA 92130 (858) 434-1113
Oncternal Therapeutics, Inc. (Filer) CIK: 0001260990 (see all company filings)

IRS No.: 621715807 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-50549 | Film No.: 231392609
SIC: 2834 Pharmaceutical Preparations